Workflow
皓元医药(688131)8月25日主力资金净流入5147.51万元

Group 1 - The stock price of Haoyuan Pharmaceutical (688131) closed at 62.68 yuan on August 25, 2025, with an increase of 6.51% and a turnover rate of 4.28% [1] - The company reported a total revenue of 606 million yuan for Q1 2025, representing a year-on-year growth of 20.05%, and a net profit attributable to shareholders of 62.38 million yuan, up 272.28% year-on-year [1] - The company has a current ratio of 2.466, a quick ratio of 1.560, and a debt-to-asset ratio of 47.96% [1] Group 2 - Haoyuan Pharmaceutical has made investments in 14 companies and participated in 17 bidding projects [2] - The company holds 64 trademark registrations and 89 patent registrations, along with 119 administrative licenses [2]